Budd-Chiari syndrome:A single-center experience

被引:4
|
作者
Tanya M Pavri [1 ]
Alan Herbst [1 ]
Rajender Reddy [1 ]
Kimberly A Forde [1 ,2 ]
机构
[1] Division of Gastroenterology and Hepatology,Perelman School of Medicine at the University of Pennsylvania,Philadelphia,PA 19104,United States
[2] Center for Clinical Epidemiology and Biostatistics,Perelman School of Medicine at the University of Pennsylvania,Philadelphia,PA 19104,United States
关键词
Budd-Chiari syndrome; Transjugular intrahepatic portosystemic shunt; Liver transplantation; Anticoagulation; Hepatic vein thrombosis;
D O I
暂无
中图分类号
R575 [肝及胆疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM:To investigate challenges,risk factors,prognostic indicators,and treatment outcomes associated with Budd-Chiari syndrome(BCS)at a tertiary care center.METHODS:A retrospective cohort study was conducted at the University of Pennsylvania in patients with a diagnosis of BCS or hepatic vein thrombosis.All patients receiving care at the University of Pennsylvania,and who had at least 2 clinical encounters in the University of Pennsylvania Health system from January1,2008 to September 10,2013 were eligible for study inclusion.Data were extracted from the electronic medical record of each patient,and recorded in a secure Research Electronic Data Capture database.Logistic regression analyses were applied to identify predictors of outcome of liver transplant(LT)or death.RESULTS:Between January 1,2008 and September10,2013,forty-seven patients were identified.Median age was 42.4 years.Thirty-one(66.0%)were women.A majority were Caucasian(68.1%).At diagnosis,43(91.5%)patients had ascites,27(57.4%)patients had a hematologic disorder associated with a hypercoagulable state and 26(55.3%)had cirrhosis.Forty(85.1%)patients were on anticoagulation(AC),30(63.8%)of whom were maintained on warfarin.Two patients(4.3%)underwent thrombolytic therapy.A transjugular intrahepatic portosystemic shunt(TIPS)was placed in21(44.7%)patients,19(90.5%)of whom were also on AC.Twenty-one(44.7%)received AC alone.Over a median of 974 d,8(17.0%)patients received LT,and10(21.3%)died.The median time from listing to death was 26 mo[interquartile range(IQR)=16,65)].TIPS with AC was utilized more frequently in younger patients(P=0.02).Age,cirrhosis and chronic kidney disease(CKD)were significant predictors of LT or death.CONCLUSION:AC alone was employed as frequently as TIPS with AC,though the latter was used more frequently in younger patients with polycythemia vera.There were no significant differences in treatment outcome regardless of the therapeutic intervention employed.Significant predictors of poor prognosis included age,cirrhosis and CKD.
引用
收藏
页码:16236 / 16244
页数:9
相关论文
共 50 条
  • [41] Systemic thrombolysis for acute, severe Budd-Chiari syndrome
    Clark, Paul J.
    Slaughter, Richard E.
    Radford, Dorothy J.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (03) : 410 - 415
  • [42] Imaging of Budd-Chiari syndrome
    O. Buckley
    J. O’ Brien
    A. Snow
    H. Stunell
    I. Lyburn
    P. L. Munk
    W. C. Torreggiani
    European Radiology, 2007, 17 : 2071 - 2078
  • [43] Management of Budd-Chiari syndrome
    Ruh, J
    Malagó, M
    Busch, Y
    Lang, H
    Paul, A
    Verhagen, R
    Broelsch, CE
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (03) : 540 - 546
  • [44] BUDD-CHIARI SYNDROME IN CHILDREN
    BOUDHINA, T
    GHRAM, N
    BENBECHER, S
    LAKHOUA, R
    AYACHI, R
    HAMMOUJEDDI, A
    BENGHACHEM, K
    BENNACEUR, B
    HAMZA, M
    ARCHIVES FRANCAISES DE PEDIATRIE, 1991, 48 (04): : 243 - 248
  • [45] Budd-Chiari syndrome: in evolution
    Bogin, V
    Marcos, A
    Shaw-Stiffel, T
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : 33 - 35
  • [46] Primary Budd-Chiari Syndrome
    Garcia-Pagan, Juan Carlos
    Valla, Dominique-Charles
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (14) : 1307 - 1316
  • [47] Histopathology of Budd-Chiari Syndrome
    Quaglia, Alberto
    DIAGNOSTICS, 2023, 13 (15)
  • [48] State of the Art, Current Perspectives, and Controversies of Budd-Chiari Syndrome: A Review
    Gavriilidis, Paschalis
    Marangoni, Gabriele
    Ahmad, Jawad
    Azoulay, Daniel
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2022, 14 (04): : 147 - 157
  • [49] Budd-Chiari syndrome management: Lights and shadows
    Andrea Mancuso
    World Journal of Hepatology, 2011, (10) : 262 - 264
  • [50] An update on the diagnosis and management of Budd-Chiari syndrome
    MacNicholas, Ross
    Olliff, Simon
    Elias, Elwyn
    Tripathi, Dhiraj
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 731 - 744